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Topic 06 – Hypertension / Vascular disease
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The stress test as a diagnostic toolfor coronary artery disease in
hypertensive patients
Samia Benghazi, Dalila Baghdadi, Rachida Habbal
CHU Ibn Rochd, Cardiologie, Casablanca, Maroc
Introduction: In hypertensive patients, there are multiplecauses of error in
the diagnosis of coronary artery disease: The objective of this study was to
evaluate the sensitivity of the positive electrical criteria in the stress test in
diagnosing coronary artery disease within the hypertensive patients. 
Materials/Methods: 120 hypertensive patients with positive stress test
underwent coronary angiography. 
Results: 33 % of patients had significant coronary lesions and 67% had
normal coronary angiography. Two groups of patients were identified:
group A ( 77 patients ) withST segment depression in DII, DIII, aVF and V6
with maximal effort and group B ( 43 patients ) with a ST segment depression
in DII, DIII, aVF and/or V4, V5, V6 with maximal effort. In group A,
65 patients (84.4%) had normal coronary angiography. In group B, 31 patients
(72%) had significant coronary lesions. In a subgroup of 46 patients in group
A with persistent ST segment depression in V4 to V6 and recovering for 4 to
6 minutes, 93% of coronary angiograms were normal. In another subgroup of
19 patients in group B with persistent ST segment depressionin V4 to V6 and
recovering for 4 to 8 minutes, 16 patients (86%) had significant lesions on
coronary angiograms. 
Conclusion: hypertensive patients with stress test showing ST segment
depression in DII, DIII, aVF and/or V4, V5, V6 on maximum effort and per-
sisting for 4-8 minutes recovering have a high probability of significant coro-
nary artery disease.
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Cardiovascular events and bleeding risk associated with intravitreal
anti-VEGF monoclonal antibodies: systematic review and meta-analysis
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Few data exists regarding the systemic safety of intravitreal anti-VEGF
monoclonal antibodies (MAb) use in people with neovascular age-related
macular degeneration (AMD), diabetic macular oedema (DMO) or retinal vein
occlusions (RVO). We performed a systematic review and meta-analysis to
evaluate the risk of major cardiovascular (MCE) and nonocular hemorrhagic
(NHE) events in AMD, DMO or RVO patients receiving intravitreal anti-
VEGF MAb. We included randomized controlled trials (RCT) comparing
ranibizumab or bevacizumab to no treatment or non-anti-VEGF treatments, or
ranibizumab to bevacizumab, in AMD, DMO or RVO patients. We used fixed
effect model and reported results as odds-ratios and their 95% CI. Primary
endpoints were major cardiovascular and nonocular hemorrhagic events.
Results: 21 RCT were retrieved (9557 patients). Anti-VEGF-MAb did not
significantly increase the risk of MCE events (1.18 [0.81, 1.71]) or NHE (1.42
[0.95, 2.13]) when compared to control. Bevacizumab did not increase the risk
of MCE (0.94 [0.59, 1.52]) or NHE (2.56 [0.78, 8.38]) when compared to
ranibizumab, but significantly increased Venous Thromboembolic Events (VTE
3.45 [1.25, 9.54]). Subgroup analysis showed a significant increase of NHE in
AMD patients in ranibizumab vs control (1.57 [1.01, 2.44]). Anti-VEGF-MAb
did not significantly increased overall mortality (1.53 [0.92, 2.56]), cardiovas-
cular mortality (1.29 [0.70, 2.37]), stroke (1.61 [0.85, 3.05]), MI (0.92 [0.54,
1.59]), VTE (1.39, [0.17, 11.38]), or hypertension (0.97 [0.71, 1.32]). 
Conclusions: the available clinical evidence showed that anti-VEGF-
MAbs were not associated with significant increases in risks of MCE or NHE,
but studies and meta-analysis were not powered enough to correctly assess
these risks. Increased risks of VTE with bevacizumab and nonocular hemor-
rhagic events in older AMD patients with ranibizumab should also be cau-
tiously interpreted, as more safety data are needed 
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Is the measurement of carotid-femoral pulse wave velocity useful in
patients with peripheral artery disease? 
Victor Aboyans (1), Aida Oueslti (2), Ileana Desormais (2), Thomas
Cautres (1), Philippe Lacroix (2)
(1) CHU Limoges, Cardiologie, Limoges, France – (2) CHU Limoges,
Hôpital Dupuytren, CTCV, Limoges, France 
Purpose: The carotid-femoral pulse-wave velocity (cfPWV) is predictive
for cardiovascular events in general population and in patients with coronary
artery disease (CAD). Patients with peripheral artery disease (PAD) are high
cardiovascular risk, but the interest of cfPWV has never been assessed in this
case. We sought to compare cfPWV in severe cases of PAD and CAD, and to
assess its prognostic value in the former group. 
Methods: From 01/12 to 06/13 we measured cfPWV in patients referred to our
hospital either for CABG or for limb revascularization for severe PAD. Patients
with CAD with ankle-brachial index <0.90 were excluded. In PAD patients, base-
line data and risk factors were compared in those with cfPWV>10m/s vs. those
≤10m/s. During follow-up, the following outcomes were collected: death, amputa-
tion and MACE (death, or stroke or myocardial infarction). 
Results: We studied 162 patients (76 with PAD and 86 with CAD, age 69
vs. 67 yrs, p=0.25), with similar sex and risk factors distribution, except for
diabetes (54% vs 20%, p<0.05). PAD patients had higher cfPWV than those
with CAD (11.3±3.7 vs. 9.8±3.0m/s, p<0.007). In patients with PAD, 50%
had a cfPWV>10m/s. These patients were older (72 vs. 66 yrs, p<0.001) with
higher rates of diabetes (76% vs 56%, p<0.001) than PAD patients with
cfPWV ≤10m/s, but did not differ regarding other risk factors. The cfPWV
was found lower in the presence of aorto-iliac disease than in case of more
distal PAD (9.5±2.5 vs. 11.8±3.9m/s, p<0.001). During follow-up of 10.5±5.7
months of PAD patients, 17.1% deceased, 5.3% had amputation, and MACE
occurred in 19.7% of cases. We found no association between cfPWV and
events (HR for death: 0.95, p=0.28; HR for amputation: 1.02, p=0.65; HR for
MACE: 0.98, p=0.29). 
Conclusion: Patients with PAD have stiffer aorta than those with CAD, as
assessed by cfPWV, in part due to higher rates of diabetes. However cfPWV
is not prognostic in patients PAD. The lower cfPWV in patients with aorto-
iliac disease may suggest measurement issues, as this velocity may be
decreased because of severe stenosis on the pulse wave trajectory. 
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R wave in aVL lead is a robust index of left ventricular hypertrophy:
a cardiac MRI study
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Objectives: in patient free from overt cardiac disease and conduction dis-
orders, R wave in aVL lead (RaVL) is better correlated than other ECG
indexes with left ventricular mass index (LVMI) assessed with transthoracic
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echocardiography. The aim of this study was to validate RaVL as an index of
left ventricular hypertrophy (LVH) using cardiac MRI (CMR) in different
conditions.
Design and methods: In a cohort of 501 patients, CMR and ECG were
performed within a median-period of 5 days. The CMR LVH cut-offs used
were 83g/m2 in men and 67g/m2 in women.
Results: In mutivariable analysis (adjusted for age, left ventricular volume,
blood pressure, age and gender), RaVL was correlated with LVMI in the
whole cohort and also in patients with or without myocardial infarction (MI):
β=0.037, p<0.001; β=0.053, p<0.001; β=0.039, p=0.010, respectively. In the
whole cohort, area under ROC curve (AUC) was 0.729 (specificity 98.3%,
sensitivity 19.6%, optimal cut-off 1.1mV, 75.8% correctly classified). In the
subgroup without MI (N=300), an optimal value of 1.0mV classified correctly
80.7% of patients (AUC 0.781, specificity 95.5%, sensitivity 35.5%). In the
subgroup with MI (N=201), RaVL had a lower diagnostic performance (AUC
0.673, specificity 97.7%, sensitivity 13.2%, optimal threshold 1.1mV). We
observed the same diagnostic performance of RaVL in women and in men
without MI (optimal threshold 1.0mV, AUC 0.788 and 0.778 respectively).
The diagnostic value of RaVL was lower in patients with left bundle branch
block (BBB) or left deviation axis in comparison with those having right BBB
(optimal threshold 1.0mV for all, AUC 0.556, 0.753 and 0.933 respectively).
Conclusion: Using the gold standard to assess LVMI, our results demon-
strated thar RaVL is a good index of LVH with a threshold around 1.0mV
independently of various clinical conditions.
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Hypertension and disability in Tunisian’s elderly
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Objective: Hypertension is another common condition in older subjects,
representing the most common morbid condition after osteoarthritis (Psaty
et al., 2001). Hypertension represents a major risk factor for cardiovascular
disease, the major source of morbidity among the over 65 population
(ISTAT, 2005). In such a context, the aims of the present study were to
investigate whether hypertension was associated independently with phys-
ical disability.
Design and Methods: A cross-sectional survey was conducted, covering a
sample of 598 subjects (202 male , 396 female, mean aged 72,3 years) aged
65 years and over. The study approved by ethics Committee and supported by
OMS and FNUAP. Information was gathered by home-based personal inter-
view using a structured questionnaire. We assessed their disability status,
sociodemographic informations and health behaviours. Disability was
recorded on three levels scale: (intense, moderate and no disability) Statistical
analysis was performed with SPSS and the significance was accepted at the p
< 0.05 level. Multiple logistic regression models were used to obtain the inde-
pendent variables associated with hypertension.
Results: The prevalence of hypertension was 52% (n=311), more frequent
for female population (55% vs 45% for male). The prevalence of disability
was 34.6%, only 10% have intense disability. Those with hypertension had
higher Body Mass Index, waist circumference and diabetes. Regarding dis-
ability, the individuals who presented the highest prevalence of hypertension
were more dependent. Multiple logistic regression revealed that the following
were significantly independent factors of hypertension: Disability (OR = 1.6).
Diabetes mellitus (OR = 2.36]).and a higher BMI (OR = 2.36).
Conclusions: We conclude that hypertension is associated not only to car-
diovascular factors (Diabetes obesity) but also with higher functional dis-
ability. Older subjects are exposed at significantly higher likelihood of
physical disability. Public health strategies to prevention hypertension in
elderly may protect them also against disability.
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Background: The sixth Joint National Committee (JNC-VI) classification
system of blood pressure emphasizes both systolic blood pressure (SBP) and
diastolic blood pressure (DBP) for cardiovascular disease risk assessment.
Pulse pressure (PP) = [SBP-DBP], may also be a valuable risk assessment
tool.
Objectives: In this study, we examined the association of cardiovascular
events with arterial pulse pressure in elderly as well as their correlations
within diabetes. 
Patients & methods: A Population based survey supported by WHO and
FNUAP, was undertaken in 2008-2009 to investigate health behaviours and
health status of elderly living in their home in Monastir. This study was car-
ried out in a representative sample of elderly aged more than 65 years. Stan-
dardized techniques were used for blood pressure (BP). Hypertension was
defined as BP more than 140/90 mmHg. Diabetes was defined as known dia-
betics. Regression analyses were used to examine the relationships among
pulse pressure age, diabetes and cardiovascular events (myocardial infarction,
arteritis and stroke).This project was approved by the research Ethics
Committee, CHU F Bourguiba, university of Monastir
Results: The study included 598 participants (396 women and 202 men)
who were aged ≥65 years. The prevalence of hypertension and diabetes was
respectively 52% (n=311) and 27,4% (n= 164). Pulse pressure was more than
65 mmHg for 132 subjects (22%), only 43 subjects without a history of hyper-
tension. The mean of PP is significantly high in hypertensive elderly (52.3 vs
58.4 mmHg), with cardiovascular events (55 vs 58 mmHg), diabetic subjects
(53 vs 58 mmHg), with comorbidity (54 vs 58 mmHg) and polymedication
(52 vs 57 mmHg). Using pulse pressure (high PP ≥65 mmHg) as dependent
variable, the multiple regression analysis reveals the independent influence of
diabetes and cardiovascular events on PP.
Conclusion: This study has confirmed that subjects with the widest PP
have the greatest risk of cardiovascular events. Elderly diabetic patients have
a higher PP than non diabetic elderly. These hemodynamic changes may
contribute to the increase risk of cardiovascular disease associated with
diabetes.
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Hypertension caused by primary hyperaldosteronism: increased heart
damage and cardiovascular risk in Algerian cohort
Hocine Foudad (1), Ilyas Bouaguel (1), Rachid Merghit (1), Aziz Trichine (1),
Abdelmoumene Mekarnia (2)
(1) Hôpital Militaire, Cardiologie, Constantine, Algérie – (2) HCA, Car-
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Introduction and objectives: Primary hyperaldosteronism is the most
common cause of secondary hypertension. Elevated aldosterone levels cause
heart damage and increase cardiovascular morbidity and mortality. Early diag-
nosis could change the course of this entity. The objective of this report was
to study the clinical characteristics, cardiac damage and cardiovascular risk
associated with primary hyperaldosteronism in Algerian cohort.
Methods: We studied 149 patients with this diagnosis. We analyzed the
reason for etiological investigation, and the routinely performed tests,
including echocardiography. We used a cohort of 590 essential hypertensive
patients followed in our hospital for comparison.
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